Intracellular Ca2+ contributes to K+-induced increase in renal kallikrein secretion

International Immunopharmacology

Volumn 6, Issue 9, 2006, Pages 1487-1495

  Fujita, Tomoe ^a   Ogino, Michiko ^a   Daigo, Futaba ^a   Yamaguchi, Tomoko ^a   Majima, Masataka ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcium; Diuretic; Potassium; Renal kallikrein secretion

Indexed keywords

CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; COUMARIN DERIVATIVE; EDETIC ACID; MACROGOL 200; METHYLCOUMARINYLAMIDE; NIFEDIPINE; POTASSIUM ION; RYANODINE; SODIUM CHLORIDE; THAPSIGARGIN; THIAZIDE DIURETIC AGENT; TISSUE KALLIKREIN; UNCLASSIFIED DRUG; VERAPAMIL; CALCIUM; KALLIKREIN; MACROGOL DERIVATIVE; POTASSIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DIURESIS; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME RELEASE; ENZYME SUBSTRATE; FLUORESCENCE; KIDNEY SLICE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION; URINE VOLUME; ANIMAL; INTRACELLULAR FLUID; KIDNEY CORTEX; METABOLISM; PHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM; INTRACELLULAR FLUID; KALLIKREINS; KIDNEY CORTEX; MALE; POLYETHYLENE GLYCOLS; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; THIAZIDES;

EID: 33745859407     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.05.003     Document Type: Article

References (35)

1. Valdes G., Vio C.P., Montero J., and Avendano R. Potassium supplementation lowers blood pressure and increases urinary kallikrein in essential hypertensives. J Hum Hypertens 5 (1991) 91-96
2. Barden A., Beilin L.J., and Vandongen R. Effect of potassium supplementation on blood pressure and vasodilator mechanisms in spontaneously hypertensive rats. Clin Sci (Lond) 75 5 (1988) 527-534
3. Whelton P.K., He J., Cutler J.A., Brancati F.L., Appel L.J., and Follman D. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 277 (1997) 1624-1632
4. Hajjar I.M., Grim C.E., George V., and Kotchen T.A. Impact of diet on blood pressure and age-related changes in blood pressure in the US population. Arch Intern Med 161 (2001) 589-593
5. Dawes M., Sieniawska C., Delves T., Dwivedi R., Chowienczyk P.J., and Ritter J.M. Barium reduces resting blood flow and inhibits potassium-induced vasodilation in the human forearm. Circulation 105 (2002) 1323-1328
6. Zhou M., Kosaka H., and Yoneyama H. Potassium augments vascular relaxation mediated by nitric oxide in the carotid arteries of hypertensive Dahl rats. Am J Hypertens 13 (2000) 666-672
7. Pamnani M.B., Bryant H.J., Clough D.L., and Schooley J.F. Increased dietary potassium and magnesium attenuate experimental volume dependent hypertension possibly through endogenous sodium-potassium pump inhibitor. Clin Exp Hypertens 25 2 (2003) 103-115
8. +-induced diuresis and natriuresis in anesthetized rats. Eur J Pharm 399 (2000) 223-227
9. Fujita T., Hayashi I., Kumagai Y., Inamura N., and Majima M. Early increases in renal kallikrein secretion on administration of potassium or ATP-sensitive channel blockers in rats. Br J Pharmacol 128 (1999) 1275-1283
10. Vio C.P., and Figueroa C.D. Evidence for a stimulatory effect of high potassium diet on renal kallikrein. Kidney Int 31 (1987) 1327-1334
11. Lauar N., and Bhoola K. Release of tissue kallikrein from the isolated perfused kidney. Adv Exp Med Biol 198 (1986) 347-354
12. Vio C.P., Olavarria V., Gonzalez C., Nazal L., Cordova M., and Balestrini C. Cellular and functional aspects of the renal kallikrein system in health and disease. Biol Res 31 (1998) 305-322
13. Gotoh S., Ogihara T., Nakamaru M., Ohde H., Higaki J., et al. Synergic effects of kallikrein-kinin and prostaglandins on rennin release on infusion of isolated hog kidney with aldosterone. Life Sci 34 (1984) 1913-1918
14. Yasujima M., Abe K., Tanno M., Sato K., Kasai Y., et al. Chronic effects of norepinephrine and vasopressin on urinary prostaglandin E and kallikrein excretions in conscious rats. Clin Exp Hypertens A 6 (1984) 1297-1310
15. Yamada K., Hasunuma K., Shiina T., Ito K., Yoshida S., Tamura T., et al. Interrelationship between urinary kallikrein and arginine-vasopressin in man. Adv Exp Med Biol 247A (1989) 621-627
16. Adachi K., Majima M., Katori M., and Nishijima M. Oxytocin-induced natriuresis mediated by the renal kallikrein-kinin system in anesthetized male rats. Jpn J Pharmacol 67 (1995) 243-252
17. Song C.K., Martinez J.A., Kailasam M.T., Dao T.T., Wong C.M., Parmer R.J., et al. Renal kallikrein excretion: role of ethnicity, gender, environment, and genetic risk of hypertension. J Hum Hypertens 14 (2000) 461-468
18. Wong C.M., O'Connor D.T., Martinez J.A., Kailasam M.T., and Parmer R.J. Diminished renal kallikrein responses to mineralocorticoid stimulation in African Americans: determinants of an intermediate phenotype for hypertension. Am J Hypertens 16 (2003) 281-289
19. Kagamimori S., Naruse Y., Matsubara I., Li Fu B., Sokejima S., and Yamagami T. Genetic and environmental effects on urinary kallikrein, catecholamines, sodium, potassium, urea nitrogen and inorganic sulfate sulfur levels in school-age twins. Hum Hered 46 (1996) 1-6
20. Fujita T., Kumagai Y., Ikeda Y., Inamura N., Iwata T., and Ogino M. Involvement of the renal kallikrein-kinin system in furosemide-induced natriuresis in rats. Jpn J Pharmacol 84 (2000) 133-139
21. Solomon R.J., Stillman N., and Weinberg M.S. Thiazide induced hypotension: the role of plasma volume reduction and the urinary kallikrein system. Adv Exp Med Biol 198 (1986) 243-251
22. Shimizu T., Yoshitomi K., Nakamura M., and Imai M. Site and mechanism of action of trichlormethiazide in rabbit distal nephron segments perfused in vitro. J Clin Invest 82 (1988) 721-730
23. Marin-Grez M., Bonner G., and Gross F. The influence of isotonic saline administration on the urinary excretion of kallikrein in rats. Biochem Pharmacol 33 (1984) 3585-3590
24. Bonner G., Marin-Grez M., Beck D., Deeg M., and Gross F. Changes in renal and urinary kallikrein activity by mannitol-induced osmotic diuresis. Clin Sci (Lond) 61 (1981) 47-51
25. Majima M., Yoshida O., Mihara H., Muto T., Mizogami S., Kuribayashi Y., et al. High sensitivity to salt in kininogen-deficient Brown Norway Katholiek rats. Hypertension 22 (1993) 705-714
26. 2+ release. J Membr Biol 158 (1997) 127-136
27. Lytton J., Westlin M., and Hanley M.R. Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem 266 (1991) 17067-17071
28. Beck F.X., Dorge A., Rick R., Schramm M., and Thurau K. Effect of potassium adaptation on the distribution of potassium, sodium and chloride across the apical membrane of renal tubular cells. Pflugers Arch 409 (1987) 477-485
29. Barrett P.Q., Ertel E.A., Smith M.M., Nee J.J., and Cohen C.J. Voltage-gated calcium currents have two opposing effects on the secretion of aldosterone. Am J Physiol 268 (1995) C985-C992
30. 2+ levels and secretion of catecholamines in cultured adrenal chromaffin cells. Neurochem Int 28 (1996) 325-334
31. 2+ channels. Naunyn Schmiedebergs Arch Pharmacol 346 (1992) 527-531
32. Yamanaka M., Hayashi I., Fujita T., Cha S.H., and Endou H. Potassium-induced increase in renal kallikrein secretion is attenuated in dissected renal connecting tubules of young spontaneously hypertensive rats. Int Immunopharmacol 2 (2002) 1957-1964
33. Roe M.W., Lancaster M.E., Mertz R.J., Worley III J.F., and Dukes I.D. Voltage-dependent intracellular calcium release from mouse islets stimulated by glucose. J Biol Chem 268 (1993) 9953-9956
34. Cibulsky S.M., and Sather W.A. Block by ruthenium red of cloned neuronal voltage-gated calcium channels. J Pharmacol Exp Ther 289 (1999) 1447-1453
35. + transport by ruthenium red. Biochem Biophys Res Commun 42 (1971) 298-305